RPL37A

Large ribosomal subunit protein eL43 · P61513 · RPL37A on Sugi Atlas →

3,559 patent compounds predicted against RPL37A, 1,840 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL5500526	0.41	4/20
SCHEMBL5500532	0.41	4/20
SCHEMBL5503310	0.41	4/20
SCHEMBL11844361	0.35	4/20
SCHEMBL2000440	0.39	3/20
SCHEMBL8219903	0.36	3/20
SCHEMBL11627320	0.34	3/20
SCHEMBL10271044	0.55	2/20
SCHEMBL6394396	0.47	2/20
N-Methylpiperidine (SCHEMBL11205373)	0.42	2/20
Bicarbonate (SCHEMBL9058396)	0.42	2/20
SCHEMBL4960293	0.41	2/20
SCHEMBL4961968	0.40	2/20
SCHEMBL6686992	0.40	2/20
SCHEMBL9429122	0.38	2/20
Chloramphenicol (SCHEMBL10796001)	1.00	1/20
Geneticin (SCHEMBL15596)	0.93	1/20
Geneticin (SCHEMBL5006573)	0.93	1/20
Geneticin (SCHEMBL9920496)	0.93	1/20
Chloramphenicol (SCHEMBL16111)	0.90	1/20

Clinical trials — most relevant to RPL37A by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes	PHASE4	UNKNOWN
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World	PHASE4	UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients	PHASE2	COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma	PHASE2	COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension	PHASE1/PHASE2	RECRUITING
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant	PHASE2	COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients	PHASE1/PHASE2	COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma	PHASE1	COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors	PHASE1	COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors	PHASE1	COMPLETED
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors	PHASE1	COMPLETED
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma	nan	COMPLETED
RibOSE - Glucose and Resistance Exercise Training	nan	COMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress	nan	WITHDRAWN
Quantification of GADD34 Expression in RA	nan	COMPLETED
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus	nan	COMPLETED
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants	nan	COMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors	nan	COMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients	nan	UNKNOWN
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)	nan	RECRUITING
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases	nan	COMPLETED
Perfusion-Induced Hyperthermia for Metastatic Carcinoma	nan	COMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide	nan	RECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic	nan	COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS)	nan	RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a RPL37A binder may also engage these)

Protein	Name	Similarity
P61514	—	1.000	P61514 →
P61515	—	1.000	P61515 →
Q5RBF9	—	1.000	Q5RBF9 →
G1SY53	—	1.000	G1SY53 →
Q3MIC0	—	1.000	Q3MIC0 →
Q7SZB4	—	1.000	Q7SZB4 →
P32046	—	1.000	P32046 →
Q90YT0	—	1.000	Q90YT0 →
Q9Y0H7	—	0.998	Q9Y0H7 →
A6NKH3	—	0.995	A6NKH3 →
O61598	—	0.995	O61598 →
Q9U2A8	—	0.994	Q9U2A8 →
Q9SRK6	—	0.993	Q9SRK6 →
Q8RXU5	—	0.993	Q8RXU5 →
P0CX25	—	0.993	P0CX25 →
A5UNQ7	—	0.992	A5UNQ7 →
A4S6Z4	—	0.992	A4S6Z4 →
Q23G98	—	0.992	Q23G98 →
Q9XHE4	—	0.992	Q9XHE4 →
B6YTZ8	—	0.991	B6YTZ8 →
Q6FRG6	—	0.991	Q6FRG6 →
P0CX26	—	0.991	P0CX26 →
Q5JDM6	—	0.991	Q5JDM6 →
O61462	—	0.990	O61462 →
A6URN7	—	0.990	A6URN7 →
Q00VK4	—	0.989	Q00VK4 →
P0DKK2	—	0.989	P0DKK2 →
P0DKK1	—	0.989	P0DKK1 →
A6VIN8	—	0.989	A6VIN8 →
O94686	—	0.989	O94686 →